A: ARTS offers assessment/evaluation, residential and outpatient drug treatment programs for adolescents, adult men and women, HIV positive individuals and offender populations.
A: Those seeking admission to a specific treatment program should call to request an evaluation. They may also call a specific location listed on this website.
- Outpatient Intake is 303-388-5894.
- Peer 1 Intake is 720-283-3695.
- Haven Intake is 303-866-7252.
- Synergy Residential is 303-781-7875.
- Synergy Outpatient is 303-934-1008.
A: Some, as long as substance abuse problems are primary.
A: Anyone can request an evaluation or treatment at ARTS. Simply call either 303-388-5894 or 303-761-6703.
A: Yes, in Colorado, minors may voluntarily apply for admission to alcohol/other drug abuse treatment, regardless of their age, without parental or legal guardian consent, as long as the treatment agency allows it and has a policy regarding this. ARTS/Synergy's policies do allow minors to be treated without parental consent or knowledge.
A: Yes. Programs meet State and Federal licensing standards.
A: Most clients are expected to pay a fee based on their ability to pay. Many services are covered by insurance, public benefits, or grants. If a client does not have a funding source, we offer a sliding scale for those who cannot afford to pay.
A: ARTS has a sliding scale for individuals with circumstances that prevent them from paying a fee. Staff will assist clients in obtaining public benefits if they are eligible. We also offer vocational training and assistance.
A: On-site day care is provided for some programs.
A: Methadone is an opiate agonist that has a series of actions similar to those of morphine and other narcotic medications. In maintenance treatment, patients are given enough methadone to ward off opiate withdrawal symptoms, but not enough to induce narcotic effects.
A: No. Used in proper doses in maintenance treatment, methadone does not create euphoria, sedation, or analgesia. Methadone has no adverse effects on motor skills, mental capability, or employability.
A: Generally, the length of time spent in treatment is positively related to treatment success. The duration of treatment should be individually determined. Treatment should last for as long as the counselor, physician and patient agree is appropriate.
A: Yes. Methadone maintenance treatment during pregnancy does not impair the child's developmental and cognitive functioning, and is the medically recommended course of treatment for most pregnant opiate-dependent women. During all stages of pregnancy, methadone is much safer for the mother and baby than continued heroin use.